Join
Live feed
·
INSIDERFilingvia Quantisnow
Sonoma Pharmaceuticals Inc. logo

Chief Financial Officer Dvonch Jerome J was granted 53,586 shares, increasing direct ownership by 173% to 84,595 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SNOA· Sonoma Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNOA (Sonoma Pharmaceuticals Inc.) and more on Quantisnow.